SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug ...
Explore advanced LIMS capabilities for pathology labs, including automated reporting, ERP billing integration, & regulatory ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果